Clinical Trials Logo

Fear of Heights clinical trials

View clinical trials related to Fear of Heights.

Filter by:
  • None
  • Page 1

NCT ID: NCT05824884 Enrolling by invitation - Fear of Heights Clinical Trials

Self-efficacy Enhancement in a Virtual Reality Training for Fear of Heights

Start date: June 22, 2023
Phase: N/A
Study type: Interventional

Self-efficacy (SE) enhancement after virtual reality exposure (VRET) for heights can promote treatment-induced effects (Raeder et al. 2019). Raeder et al (2019) employed an intervention to enhance SE by introducing specific questions about autobiographical events of success and mastery experiences in the course of VRET. Building on these previous findings, the present study aims to examine whether SE-enhancement DURING and/or AFTER a brief VR-based exposure for fear of heights (in the following referred to as VR-height-exposure) is suitable to promote exposure-induced reductions in height-related fear and avoidance. To this end, repeated visual feedback DURING a brief VR-height-exposure will be used to selectively promote SE and mastery experiences. In a similar vein, SE-enhancement AFTER VR-height-exposure will be administered. The effects of these interventions will be assessed on different treatment outcome levels. It will be further examined whether the combined SE enhancement (DURING and AFTER exposure) is more effective that 1.) SE enhancement performed DURING VR-height-exposure only or 2.) SE enhancement performed AFTER VR-height-exposure only. The investigators hypothesize that SE enhancement (either administered DURING or AFTER VR-height-exposure) will be more effective (as indicated by more pronounced reductions in height-related fear and avoidance) than VR-height-exposure alone. It is further expected that the combined SE enhancement DURING and AFTER VR-height-exposure will be more effective compared to SE enhancement DURING VR-height-exposure alone and/or SE enhancement DURING VR-height-exposure alone.

NCT ID: NCT04975854 Completed - Anxiety Disorders Clinical Trials

Virtual Reality Exposure Therapy for Acrophobia

Start date: July 13, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to examine the efficacy of virtual reality exposure therapy (VRET) as a treatment for specific phobia (acrophobia). The study will randomly assign 42 participants with acrophobia to one of two conditions: a) the experimental condition (consisting of 3 sessions of virtual reality exposure) or b) a control condition. Both groups will receive short information session about general principles of exposure therapy before the start of the study. After the end of the study, the waitlist group will be invited to attend the short version (one or two-sessions) of the VRET. Both groups will receive a final follow-up questionnaires 2 months after the last session.

NCT ID: NCT04737915 Completed - Anxiety Disorder Clinical Trials

Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights

Start date: June 11, 2018
Phase: N/A
Study type: Interventional

This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition. The aim of this study was to compare the efficacy of virtual reality exposure to the efficacy of in vivo exposure or no exposure for participants with significant fear of heights.

NCT ID: NCT04003753 Completed - Fear of Heights Clinical Trials

Efficacy of a VR Paradigm to Reduce Fear of Heights in a Clinical and Subclinical Population With Fear of Heights

VRAP-Basel
Start date: October 16, 2018
Phase: N/A
Study type: Interventional

Investigation of the effectiveness and acceptability and usability of a VR height exposure App in individuals with fear of heights.

NCT ID: NCT03917433 Suspended - Anxiety Disorders Clinical Trials

Augmenting Virtual Reality Exposure Therapy for Acrophobia

Start date: April 10, 2019
Phase: N/A
Study type: Interventional

This study will examine whether tactile feedback and point-based rewards can be used to improve outcomes from virtual reality exposure therapy for acrophobia.

NCT ID: NCT03907345 Completed - Fear of Heights Clinical Trials

Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After Exposure

Start date: June 6, 2019
Phase: N/A
Study type: Interventional

This study investigates whether a one-session exposure treatment for spider-related stimuli can lead to a generalization of extinguished fear to height-related stimuli in individuals with comorbid fear of spiders and fear of heights.

NCT ID: NCT02361203 Completed - Fear of Heights Clinical Trials

Exercise and Virtual Reality Exposure Therapy for Acrophobia

Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether aerobic exercise can enhance the effects of exposure therapy treatment for fear of heights.

NCT ID: NCT00302978 Completed - Fear of Heights Clinical Trials

Changes in Brain Activity (Functional MRI Study) Before and After Behavioral Therapy of Height Phobia

Start date: March 2006
Phase: N/A
Study type: Interventional

We are interested in investigating the functional brain abnormalities of height phobia. Subjects will be have a functional MRI scan before and after a course of treatment with behavioral therapy.